Valuation: Central PharmaceuticalNo3

Market Cap 1,311B 50.22M 43.04M 40.32M 36.83M 69.51M 4.79B 70.2M 476M 185M 2.42B 189M 184M 8B P/E 2024
10.3x
P/E 2025 7.27x
Enterprise Value 870B 33.33M 28.56M 26.76M 24.44M 46.13M 3.18B 46.58M 316M 123M 1.6B 125M 122M 5.31B EV / Sales 2024
2.18x
EV / Sales 2025 1.58x
Free-Float
27.45%
Yield 2024
5.15%
Yield 2025 7.58%
07-23 Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
04-21 Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
01-21 Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the Full Year Ended December 31, 2025 CI
21/10/25 Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
19/07/25 Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
19/04/25 Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
20/01/25 Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
23/07/24 Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
23/04/24 Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
23/01/24 Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
23/10/23 Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
24/07/23 Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
21/04/23 Central Pharmaceutical Joint Stock Company No3 Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
1 week+2.01%
Current month+0.49%
1 month-0.33%
3 months+4.63%
6 months-3.17%
Current year+15.53%
1 week 60,000
Extreme 60000
62,600
1 month 58,100
Extreme 58100
62,600
Current year 52,000
Extreme 52000
67,500
1 year 47,000
Extreme 47000
67,500
3 years 47,000
Extreme 47000
77,000
5 years 34,800
Extreme 34800
80,800
10 years 10,600
Extreme 10600
80,800
Manager TitleAgeSince
Chief Executive Officer 50 01/06/2019
Comptroller/Controller/Auditor - 18/07/2019
Director TitleAgeSince
Chairman 65 01/01/2012
Director/Board Member 62 24/04/2014
Director/Board Member 50 01/03/2017
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+2.01%+17.08%-3.48% 50.12M
+0.50%+2.50%+80.69%+126.93% 1,111B
+0.43%+0.62%+52.91%+64.09% 658B
+0.60%+2.82%+28.27%+81.49% 467B
+0.92%+3.57%+43.82%+44.21% 369B
+1.25%+2.21%+26.77%+43.05% 301B
+3.02%+5.68%+5.09%+17.04% 256B
+0.16%+4.41%+53.92%+73.19% 240B
+2.86%+3.86%-16.20%-51.83% 207B
+0.78%+2.99%+29.42%+92.21% 182B
Average +1.07%+4.19%+32.18%+48.69% 379.11B
Weighted average by Cap. +0.92%+4.68%+47.00%+73.48%

Financials

2024 2025
Net sales 417B 15.99M 13.7M 12.84M 11.73M 22.13M 1.52B 22.35M 151M 58.94M 769M 60.03M 58.72M 2.55B 438B 16.77M 14.37M 13.46M 12.3M 23.21M 1.6B 23.44M 159M 61.83M 807M 62.97M 61.6M 2.67B
Net income 121B 4.64M 3.98M 3.73M 3.4M 6.42M 442M 6.49M 43.95M 17.11M 223M 17.42M 17.04M 739M 156B 5.98M 5.12M 4.8M 4.38M 8.27M 570M 8.35M 56.6M 22.04M 287M 22.44M 21.95M 952M
Net Debt -342B -13.08M -11.21M -10.51M -9.6M -18.11M -1.25B -18.29M -124M -48.24M -629M -49.13M -48.06M -2.08B -441B -16.89M -14.48M -13.57M -12.39M -23.38M -1.61B -23.62M -160M -62.29M -813M -63.44M -62.05M -2.69B
Logo Central PharmaceuticalNo3
Central Pharmaceutical Joint Stock Company No3 (FORIPHARM) is a Vietnam-based company operating in the pharmaceutical industry, which is mainly engaged in the manufacture and trading of pharmaceutical products. The Company's leading products include botanical medicine and other types of drugs, health supplements and cosmetics, among others. Besides, the Company partakes in the commerce of medical equipment and supplies, as well as the conduct of medical research.
Employees
-
Date Price Change Volume
25/08/26 61,000.00 0.00% 8,581
24/08/26 ₫61,000.00 -0.81% 13,013
21/08/26 ₫61,500.00 +1.15% 2,130
20/08/26 ₫60,800.00 +1.16% 8,357
19/08/26 ₫60,100.00 0.00% 11,021

Annual profits - Rate of surprise